Add to Favorite
Product
Suppliers
MSDS
Home
>>
Chemicals Listing
>>
hot product list by L
L-Glutamine,N-[(1S,2R)-2-[(3S,5S)-3,5-dimethoxy-2-methyl-6-oxo-1-cyclohexen-1-yl]-2-hydroxy-1-methylethyl]-(9CI) (129421-88-1)
Identification
Name:
L-Glutamine,N-[(1S,2R)-2-[(3S,5S)-3,5-dimethoxy-2-methyl-6-oxo-1-cyclohexen-1-yl]-2-hydroxy-1-methylethyl]-(9CI)
Synonyms:
L-Glutamine,N-[2-(3,5-dimethoxy-2-methyl-6-oxo-1-cyclohexen-1-yl)-2-hydroxy-1-methylethyl]-,[3S-[1(1R*,2S*),3a,5b]]-; Lascivol
CAS:
129421-88-1
Molecular Formula:
C17H28 N2 O7
Molecular Weight:
0
InChI:
InChI=1/C17H28N2O7/c1-8-11(25-3)7-12(26-4)16(22)14(8)15(21)9(2)19-10(17(23)24)5-6-13(18)20/h9-12,15,19,21H,5-7H2,1-4H3,(H2,18,20)(H,23,24)/t9-,10-,11-,12-,15-/m0/s1
Molecular Structure:
Properties
Flash Point:
354.4°C
Boiling Point:
662.4°C at 760 mmHg
Density:
1.26g/cm
3
Refractive index:
1.537
Flash Point:
354.4°C
Safety Data
Other Product
2-Butenoicacid, 4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-ylester, (2E)-
2-Butenoic acid,4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,(2R,4R,5S,6R)-tetrahydro-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-2-methoxy-5-methyl-6-(1-methylethyl)-2H-pyran-4-ylester, (2E)-
Oxacyclohexadeca-3,5,11,13-tetraen-2-one,16-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(6-deoxy-2-O-methyl-a-L-mannopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-,(3Z,5E,7R,8S,9S,11E,13E,15S,16R)- (9CI)
Cyclopentanecarboxylic acid, 3-hydroxy-2-methyl-5-(1-methylethenyl)-, methyl ester, (1S,2R,3S,5S)- (9CI)
2-Butenedioic acid(2E)-,1-[(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl]ester
2-Butenedioic acid(2E)-,1-[(2R,4R,5S,6R)-tetrahydro-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-2-methoxy-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl]ester
L-Idonamide,6-cyclohexyl-2,4,6-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-[[3-hydroxy-2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxobutyl]amino]-2-(1-methylethyl)-,[1S-[1a(2R*,3S*),2a]]- (9CI)
Nα-[O-Methyl-N-[[(3S,4R)-3,4-dihydroxypyrrolizino]carbonyl]-L-tyrosyl]-N-[(1S,2R)-1-(cyclohexylmethyl)-2-[(5S)-3-ethyl-2-oxo-5-oxazolidinyl]-2-hydroxyethyl]-L-histidinamide
Cyclohexanethiol,5-methyl-2-(1-methylethyl)-,(1S,2R,5S)-(9CI)
D-Threonine,(3S)-N-[(2S)-2-[(2R,5S,6S)-6-[(1E,3S,5E)-3-ethyl-1,5-dimethyl-4-oxo-1,5-heptadien-1-yl]tetrahydro-2-hydroxy-5-methyl-2H-pyran-2-yl]-2-hydroxy-1-oxobutyl]-3-hydroxy-L-leucyl-(3R)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-O-methyl-L-seryl-N-methyl-D-alanyl-(3S)-hexahydro-3-pyridazinecarbonyl-,(6®13)-lactone
2-Butenoic acid,4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,(2R,4R,5S,6R)-2-[(1S,2R,3S)-3-[(2R,3S,4E,6E,9R,10S,11S,12R,13R,14E,16Z)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6,14,16-tetraen-2-yl]-2-hydroxy-1-methylbutyl]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propen-1-yl-2H-pyran-4-ylester
L-Idonamide,6-cyclohexyl-2,5,6-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-2-(1-methylethyl)-5-[[2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxo-3-(phosphonooxy)butyl]amino]-,dipotassium salt, [1(1S,2R),5(2S,3R)]- (9CI)
2-Butenoic acid,4-amino-4-oxo-,(2R,4R,5S,6R)-6-ethyltetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-2H-pyran-4-ylester, (2E)- (9CI)
Oxacyclohexadeca-3,5,11,13-tetraen-2-one,8-hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl-,(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-
2-Cyclohexen-1-one,6-hydroxy-2-methyl-5-(1-methylethyl)-,(5S,6S)-(9CI)
2-Cyclohexen-1-one,6-[(1S)-1-hydroxy-2-methyl-2-propen-1-yl]-2-methyl-5-(1-methylethyl)-,(5S,6R)-
2-Furantridecanoic acid,tetrahydro-5-[(1S,3S)-1-hydroxy-3-methylundecyl]-, methyl ester,(2R,5S)-
6-Oxabicyclo[3.2.1]octan-7-one,8-[2-[(3S)-3-hydroxy-3-(1-methylethyl)-6-oxo-1-cyclohexen-1-yl]ethyl]-1,5-dimethyl-, (1R,5S,8S)-
2-Cyclohexen-1-ol,5-fluoro-2-methyl-5-(1-methylethyl)-,(1S,5S)-(9CI)
2-Pyridinamine,6-[[(1S,2R,5S)-5-methyl-2-(1-methylethyl)cyclohexyl]oxy]-N-2-pyridinyl-
About Us
|
Service
|
Contact Us
|
Feedback
|
Links
|
Add to Favorite
Copyright©2012 Hangzhou Dingyue Network Co., Ltd. ICP: B2-20090288
浙ICP备09045134号-1
Tel: +86-0571-89739792